HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adult onset Still's disease: response to Enbrel.

AuthorsR A Asherson, L Pascoe
JournalAnnals of the rheumatic diseases (Ann Rheum Dis) Vol. 61 Issue 9 Pg. 859-60; author reply 860 (Sep 2002) ISSN: 0003-4967 [Print] England
PMID12176823 (Publication Type: Case Reports, Comment, Letter, Review)
Chemical References
  • Antibodies, Monoclonal
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Etanercept
Topics
  • Adult
  • Antibodies, Monoclonal (therapeutic use)
  • Etanercept
  • Female
  • Humans
  • Immunoglobulin G (therapeutic use)
  • Infliximab
  • Receptors, Tumor Necrosis Factor (therapeutic use)
  • Still's Disease, Adult-Onset (drug therapy)
  • Tumor Necrosis Factor-alpha (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: